Expert Opin Investig Drugs 32(5):355359 Urva S, Coskun T, Loh MT, Du Y, Thomas MK, Gurbuz S et al (2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Choline: Choline supports the health of the liver by processing and excreting chemical waste products
Encouraging dialogue between patients and doctors about possible medication alternatives and closely monitoring for any adverse effects to help mitigate risks
Bush Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK
The co-occurrence of symptoms was examined through a cluster analysis, which mapped connections between side effects frequently mentioned together, helping to identify common symptom groupings